Key terms

About IFRX

InflaRx NV is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a and its receptor C5aR. Its primary product candidate is Vilobelimab. The company was founded by Niels Christoph Riedemann, Renfeng Guo, and Nicolas Fulpius in December 2007 and is headquartered in Jena, Germany.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest IFRX news

Apr 04 4:58pm ET InflaRx N.V. Announces 2024 AGM Details by TipRanks Mar 24 9:25pm ET Investor Optimism for InflaRx’s INF904: Assessing Potential in CSU and HS Markets by TipRanks Mar 22 3:05pm ET LifeSci Capital Reaffirms Their Hold Rating on InflaRx (IFRX) by TipRanks Mar 22 6:16am ET Buy Rating Justified for InflaRx Despite Earnings Miss: Financial Stability and INF904’s Market Potential by TipRanks Mar 21 9:27pm ET InflaRx Advances Anti-Inflammatory Therapeutics by TipRanks Mar 21 7:57am ET InflaRx N.V. Targets Immuno-Dermatology Growth by TipRanks Mar 21 7:08am ET InflaRx announces INF904 development plans by TipRanks Mar 21 7:06am ET InflaRx sees cash runway into at least 2026 by TipRanks Mar 21 7:05am ET InflaRx reports 2023 EPS (EUR 0.78) vs. (EUR 0.67) last year by TipRanks Feb 22 7:46am ET InflaRx appoints Medina as Head of Investor Relations by TipRanks Jan 25 11:25am ET Buy Recommendation for InflaRx Amidst Strategic Initiatives and Promising Clinical Advances by TipRanks Jan 25 11:14am ET InflaRx price target lowered to $8 from $9 at H.C. Wainwright by TipRanks Jan 25 7:32am ET InflaRx announces initiation of its commitment program for GOHIBIC by TipRanks Jan 09 1:30am ET Analysts Offer Insights on Healthcare Companies: Walgreens Boots Alliance (WBA), InflaRx (IFRX) and Eli Lilly & Co (LLY) by TipRanks Jan 05 6:28am ET InflaRx’s Promising INF904 Phase 1 Results Prompt Buy Rating by TipRanks

No recent press releases are available for IFRX

IFRX Financials

1-year income & revenue

Key terms

IFRX Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

IFRX Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

NEW YORK, NEW YORK - FEBRUARY 08: A New York Community Bank stands in Brooklyn on February 08, 2024 in New York City. New York Community Bancorp, a regional lender, shed about 60% of its value over the past eight days and its credit rating has been downgraded to Junk by Moody's. (Photo by Spencer Platt/Getty Images)
Spencer Platt/Getty Images
US regional banks are still under pressure. That’s likely to continue
Trump Media, which runs the social media platform Truth Social, took the place of Digital World's place on the Nasdaq stock exchange in March.
Frank Franklin II/AP
Trump Media stock ends session 15% higher after two very bad days
Students at Highlands High School, work on a practice test at the ACT Boot Camp in Newport, Ky.
Patrick Reddy/The Enquirer/AP/File
Private equity finds its next bet: college admissions
In this photo illustration, Republican presidential candidate former President Donald Trump's social media platform Truth Social is shown on a cell phone on March 25, 2024 in Chicago, Illinois.
Scott Olson/Getty Images
Trump’s stock tumbles again after Truth Social announces it’s getting into streaming